+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biologics Contract Development Market Size, Share & Trends Analysis Report By Source (Mammalian, Microbial), By Service Type, By Indication (Oncology, Immunological Disorders), By Region And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 150 Pages
  • June 2023
  • Region: Global
  • Grand View Research
  • ID: 5144632
Description Jump to:

The global biologics contract development market size is expected to reach USD 13.8 billion by 2030, expanding at 8.1% CAGR from 2023 to 2030. Key drivers attributed to the growth include rising adoption of advanced technologies by biologics manufacturers, M&A, and clinical trials in developing nations. The market includes organizations that offer services such as the development of cell lines, upstream and downstream processes, analytical methods, and formulations. These organizations specialize in developing and manufacturing stable cell lines that are extensively used in several important applications, including drug screening, gene functional studies, and biologic production.

Growing M&A and collaboration activities between biopharma companies and CDOs are yet another factor assisting in market growth allowing more financial stability and amalgamation of advanced & specialized technologies. For instance, in September 2022, Lonza., collaborated with biotechnology company Touchlight to expand its product portfolio with different sources of DNA for developing mRNA. Touchlight entered into this partnership to expand its consumer base to the novel doggybone DNA (dbDNA) technology via Lonza's offerings.

Many biopharma and Pharma companies are increasingly looking to outsource their activities as it helps accelerate the workflow (speed) of the company, provide unique specialized services, decrease drug development costs, and provide expertise. These factors are expected to boost the biologics contract development industry's growth.

During the COVID-19 pandemic, most clinical trials were focused on developing new therapies for treating COVID-19. However, in the post-pandemic period, research is expected to focus on cancer owing to rising incidences. Biologics such as monoclonal antibodies have gained significant popularity in treating cancer. The high potential of biologics in treating cancer and the growing number of cancer studies are likely to support the growth of the market in the coming years.

Biologics Contract Development Market Report Highlights

  • Mammalian source emerged as the largest product segment in 2022 with over 52.0% share, as the majority of research is being carried out using mammalian cell lines
  • Process development is expected to witness the highest CAGR over the forecast period, as many companies are opting to outsource the production of recombinant proteins and monoclonal antibodies (MABs)
  • North America dominated the global market in 2019. An increase in strategic acquisitions & partnerships and a rise in demand for specialized testing services are likely to have a positive impact
  • Asia Pacific is expected to register the highest CAGR over the forecast period, owing to various amendments made by regulatory organizations to change clinical trials evaluation standards in tandem with global requirements and rising investment in the Asia Pacific region

Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation & Scope
1.1.1 Source Type
1.1.2 Service Type
1.1.3 Disease Indication Type
1.1.4 Regional Scope
1.1.5 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Region-Wise Market Calculation
1.6.1 Region-Wise Market: Base Estimates
1.6.2 Global Market: Cagr Calculation
1.7 Model Details
1.7.1 Commodity Flow Analysis (Model 1)
1.7.2 Volume Price Analysis (Model 2)
1.7.2.1 Service Segment Analysis
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 List Of Secondary Sources
1.11 Objectives
1.11.1 Objective - 1:
1.11.2 Objective - 2:
1.11.3 Objective - 3:
1.11.4 Objective - 4:

Chapter 2 Executive Summary
2.1 Market Outlook

Chapter 3 Biologics Contract Development Market: Variables, Trends, & Scope
3.1 Market Segmentation And Scope
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Increasing Adoption Of Advanced Technologies
3.2.3 Increasing Mergers And Collaborations
3.2.4 Favorable Environment For Clinical Trials In Developing Countries
3.2.5 Increasing Outsourcing Of R&D Activities
3.2.6 Market Restraint Analysis
3.2.7 Intellectual Property Rights Issues
3.3 Penetration & Growth Prospect Mapping
3.4 Biologics Contract Development: Market Analysis Tools
3.4.1 Industry Analysis - Porter’s Five Forces
3.4.2 Pestel Analysis
3.5 COVID-19 Impact On The Biologics Contract Development Market

Chapter 4 Biologics Contract Development Market: Source Type Segment Analysis
4.1 Biologics Contract Development Market: Market Share Analysis, 2022 & 2030
4.1.1 Microbial
4.1.1.1 Microbial Market, 2018 - 2030 (USD Million)
4.1.1.2 Mammalian
4.1.1.2.1 Mammalian Market, 2018 - 2030 (USD Million)
4.1.1.3 Others
4.1.1.3.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Biologics Contract Development Market: Service Segment Analysis
5.1 Biologics Contract Development Market: Market Share Analysis, 2022 & 2030
5.2 Cell Line Development
5.2.1 Cell Line Development Market, 2018 - 2030 (USD Million)
5.2.1.1 Microbial Cell Line Development
5.2.1.1.1 Microbial Cell Line Development Market, 2018 - 2030 (USD Million)
5.2.1.2 Mammalian Cell Line Development
5.2.1.2.1 Mammalian Cell Line Development Market, 2018 - 2030 (USD Million)
5.2.1.3 Others
5.2.1.3.1 Others Market, 2018 - 2030 (USD Million)
5.2.2 Process Development
5.2.2.1 Process Development market, 2018 - 2030 (USD Million)
5.2.2.2 Upstream Process Development
5.2.2.1.1 Upstream Process Development Market, 2018 - 2030 (USD Million)
5.2.2.1.1.1 Microbial
5.2.2.1.1.1.1 Microbial Market, 2018 - 2030 (USD Million)
5.2.2.1.2.1 Mammalian
5.2.2.1.2.1.1 Mammalian Market, 2018 - 2030 (USD Million)
5.2.2.1.3.1 Others
5.2.2.1.3.1.1 Others Market, 2018 - 2030 (USD Million)
5.2.3 Downstream Process Development
5.2.3.1 Downstream Process Development, 2018 - 2030 (USD Million)
5.2.3.1.1 Impurity, Isolation, & Identification
5.2.3.1.1.1 Impurity, Isolation, & Identification Market, 2018 - 2030 (USD Million)
5.2.3.1.2 Physicochemical Characterization
5.2.3.1.2.1 Physicochemical Characterization Market, 2018 - 2030 (USD Million)
5.2.3.1.3 Pharmaceutical Analysis
5.2.3.1.3.1 Pharmaceutical Analysis Market, 2018 - 2030 (USD Million)
5.2.3.1.4 Others
5.2.3.1.4.1 Others Market, 2018 - 2030 (USD Million)
5.3.4 Downstream Process, By Product
5.3.4.1 Mabs (Monoclonal Antibodies)
5.3.4.1.1 Mabs (Monoclonal Antibodies) Market, 2018 - 2030 (USD Million)
5.3.4.2. Recombinant Proteins
5.3.4.2.1 Recombinant Proteins Analysis Market, 2018 - 2030 (USD Million)
5.3.4.3 Others
5.3.4.3.1 Others Market, 2018 - 2030 (USD Million)
5.3 Other Services (Quality And Regulatory Services, Etc)
5.3.1 Others Market, 2018 - 2030 (USD Million)

Chapter 6 Biologics Contract Development Market: Indication Segment Analysis
6.1 Biologics Contract Development Market: Market Share Analysis, 2022 & 2030
6.2 Oncology
6.2.1 Oncology Market, 2018 - 2030 (USD Million)
6.3 Immunological Disorders
6.3.1 Immunological Disorders Market, 2018 - 2030 (USD Million)
6.4 Cardiovascular Disorders
6.4.1 Cardiovascular Disorders Market, 2018 - 2030 (USD Million)
6.5 Hematological Disorders
6.5.1 Hematological Disorders Market, 2018 - 2030 (USD Million)
6.6 Others
6.6.1 others Market, 2018 - 2030 (USD Million)

Chapter 7 Biologics Contract Development Market: Regional Analysis
7.1 Biologics Contract Development: Regional Market Share Analysis, 2022 & 2030
7.2 North America
7.2.1 North America Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.3.2 UK
7.3.2.1 UK Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.3.3 Germany
7.3.3.1 Germany Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 France Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Italy Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.4.2 China
7.4.2.1 China Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.4.3 India
7.4.3.1 India Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.4.4 Japan
7.4.4.1 Japan Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.4.5 Australia
7.4.5.1 Australia Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.5.5 Colombia
7.5.5.1 Colombia Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.6 MEA
7.6.1 MEA Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.6.4 UAE
7.6.4.1 UAE Biologics Contract Development Market, 2018 - 2030 (USD Million)

Chapter 8 Company Profiles
8.1 Competitive Landscape
8.2 Company Profile
8.2.1 Wuxi Biologics
8.2.1.1 Company Overview
8.2.1.2 Financial Performance
8.2.1.3 Service Benchmarking
8.2.1.4 Strategic Initiatives
8.2.2 Abzena Ltd
8.2.2.1 Company Overview
8.2.2.2 Service Benchmarking
8.2.2.3 Strategic Initiatives:
8.2.3 Fujifilm Diosynth Biotechnologies
8.2.3.1 Company Overview
8.2.3.2 Financial Performance
8.2.3.3 Service Benchmarking
8.2.3.4 Strategic Initiatives
8.2.4 Kbi Biopharma
8.2.4.1 Company Overview
8.2.4.2 Service Benchmarking
8.2.4.3 Strategic Initiatives
8.2.5 Agc Biologics
8.2.5.1 Company Overview
8.2.5.2 Financial Performance
8.2.5.3 Service Benchmarking
8.2.5.4 Strategic Initiatives:
8.2.6 Thermo Fischer Scientific Inc.
8.2.6.1 Company Overview
8.2.6.2 Financial Performance
8.2.6.3 Service Benchmarking
8.2.6.4 Strategic Initiatives:
8.2.7 Curia Global, Inc
8.2.7.1 Company Overview
8.2.7.2 Service Benchmarking
8.2.7.3 Strategic Initiatives:
8.2.8 Genscript
8.2.8.1 Company Overview
8.2.8.2 Financial Performance
8.2.8.3 Service Benchmarking
8.2.8.4 Strategic Initiatives
8.2.9 Bionova Scientific Inc.
8.2.9.1 Company Overview
8.2.9.2 Service Benchmarking
8.2.10 Bioxcellence (Boehringer Ingelheim Biopharmaceuticals Gmbh)
8.2.10.1 Company Overview
8.2.10.2 Financial Performance
8.2.10.3 Service Benchmarking
8.2.10.4 Strategic Initiatives:
8.2.11 Stc Biologics
8.2.11.1 Company Overview
8.2.11.2 Service Benchmarking

List of Tables
Table 1: List of Secondary Sources
Table 2: List of Abbreviations
Table 3: Global Biologics Contract Development Market, By Region, 2018-2030 (USD Million)
Table 4: Global Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 5: Global Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 6: Global Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 7: North America Biologics Contract Development Market, By Country, 2018-2030 (USD Million)
Table 8: North America Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 9: North America Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 10: North America Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 11: U.S. Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 12: U.S. Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 13: U.S. Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 14: Canada Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 15: Canada Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 16: Canada Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 17: Europe Biologics Contract Development Market, By Country, 2018-2030 (USD Million)
Table 18: Europe Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 19: Europe Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 20: Europe Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 21: Germany Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 22: Germany Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 23: Germany Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 24: UK Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 25: UK Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 26: UK Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 27: France Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 28: France Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 29: France Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 30: Italy Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 31: Italy Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 32: Italy Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 33: Spain Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 34: Spain Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 35: Spain Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 36: Denmark Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 37: Denmark Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 38: Denmark Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 39: Sweden Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 40: Sweden Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 41: Sweden Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 42: Norway Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 43: Norway Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 44: Norway Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 45: Asia Pacific Biologics Contract Development Market, By Country, 2018-2030 (USD Million)
Table 46: Asia Pacific Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 47: Asia Pacific Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 48: Asia Pacific Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 49: China Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 50: China Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 51: China Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 52: Japan Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 53: Japan Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 54: Japan Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 55: India Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 56: India Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 57: India Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 58: Australia Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 59: Australia Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 60: Australia Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 61: South Korea Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 62: South Korea Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 63: South Korea Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 64: Thailand Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 65: Thailand Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 66: Thailand Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 67: Latin America Biologics Contract Development Market, By Country, 2018-2030 (USD Million)
Table 68: Latin America Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 69: Latin America Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 70: Latin America Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 71: Brazil Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 72: Brazil Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 73: Brazil Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 74: Mexico Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 75: Mexico Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 76: Mexico Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 77: Argentina Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 78: Argentina Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 79: Argentina Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 80: Colombia Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 81: Colombia Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 82: Colombia Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 83: Middle East and Africa Biologics Contract Development Market, By Country, 2018-2030 (USD Million)
Table 84: Middle East and Africa Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 85: Middle East and Africa Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 86: Middle East and Africa Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 87: South Africa Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 88: South Africa Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 89: South Africa Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 90: Saudi Arabia Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 91: Saudi Arabia Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 92: Saudi Arabia Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 93: UAE Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 94: UAE Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 95: UAE Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
Table 96: Kuwait Biologics Contract Development Market, by Source, 2018-2030 (USD Million)
Table 97: Kuwait Biologics Contract Development Market, by Service, 2018-2030 (USD Million)
Table 98: Kuwait Biologics Contract Development Market, by Indication, 2018-2030 (USD Million)
List of Figures
Fig. 1: Market research process
Fig. 2: Information procurement
Fig. 3: Primary research pattern
Fig. 4: Market research approaches
Fig. 5: Value-chain-based sizing & forecasting
Fig. 6: QFD modeling for market share assessment
Fig. 7: Market formulation & validation
Fig. 8: Commodity flow analysis
Fig. 9: Volume Price Analysis
Fig. 10: Biologics Contract Development market snapshot (2022)
Fig. 11: Biologics Contract Development market segmentation
Fig. 12: Market driver relevance analysis (Current & future impact)
Fig. 13: Market restraint relevance analysis (Current & future impact)
Fig. 14: Penetration & growth prospect mapping
Fig. 15: Porter’s five forces analysis
Fig. 16: SWOT analysis, by factor (political & legal, economic and technological)
Fig. 17: Biologics Contract Development market product type outlook: Segment dashboard
Fig. 18: Biologics Contract Development market: product movement analysis
Fig. 19: Microbial market, 2018-2030 (USD Million)
Fig. 20: Mammalian market, 2018-2030 (USD Million)
Fig. 21: Others market, 2018-2030 (USD Million)
Fig. 22: Biologics Contract Development market service outlook: Segment dashboard
Fig. 23: Biologics Contract Development market: product movement analysis
Fig. 24: Cell Line Development market, 2018-2030 (USD Million)
Fig. 25: Microbial Cell Line Development market, 2018-2030 (USD Million)
Fig. 26: Mammalian Cell Line Development market, 2018-2030 (USD Million)
Fig. 27: Others market, 2018-2030 (USD Million)
Fig. 28: Process development market, 2018-2030 (USD Million)
Fig. 29: Upstream Process Development market, 2018-2030 (USD Million)
Fig. 30: Microbial market, 2018-2030 (USD Million)
Fig. 31: Mammalian market, 2018-2030 (USD Million)
Fig. 32: Others market, 2018-2030 (USD Million)
Fig. 33: Downstream Process Development market, 2018-2030 (USD Million)
Fig. 34: Impurity, isolation, & identification market, 2018-2030 (USD Million)
Fig. 35: Physicochemical characterization market, 2018-2030 (USD Million)
Fig. 36: Pharmaceutical analysis market, 2018-2030 (USD Million)
Fig. 37: Others market, 2018-2030 (USD Million)
Fig. 38: MABS (Monoclonal Antibodies) market, 2018-2030 (USD Million)
Fig. 39: Recombinant proteins market, 2018-2030 (USD Million)
Fig. 40: Others market, 2018-2030 (USD Million)
Fig. 41: Others market, 2018-2030 (USD Million)
Fig. 42: Biologics Contract Development market indication outlook: Segment dashboard
Fig. 43: Biologics Contract Development market: indication movement analysis
Fig. 44: Oncology market, 2018-2030 (USD Million)
Fig. 45: Immunological disorders market, 2018-2030 (USD Million)
Fig. 46: Cardiovascular disorders market, 2018-2030 (USD Million)
Fig. 47: Hematological disorders market, 2018-2030 (USD Million)
Fig. 48: Others market, 2018-2030 (USD Million)
Fig. 49: Regional market: Key takeaways
Fig. 50: Regional outlook, 2022 & 2030
Fig. 51: North America market, 2018-2030 (USD Million)
Fig. 52: U.S. market, 2018-2030 (USD Million)
Fig. 53: Canada market, 2018-2030 (USD Million)
Fig. 54: Europe market, 2018-2030 (USD Million)
Fig. 55: UK market, 2018-2030 (USD Million)
Fig. 56: Germany market, 2018-2030 (USD Million)
Fig. 57: France market, 2018-2030 (USD Million)
Fig. 58: Italy market, 2018-2030 (USD Million)
Fig. 59: Spain market, 2018-2030 (USD Million)
Fig. 60: Asia Pacific market, 2018-2030 (USD Million)
Fig. 61: China market, 2018-2030 (USD Million)
Fig. 62: India market, 2018-2030 (USD Million)
Fig. 63: Japan market, 2018-2030 (USD Million)
Fig. 64: Australia market, 2018-2030 (USD Million)
Fig. 65: South Korea market, 2018-2030 (USD Million)
Fig. 66: Latin America market, 2018-2030 (USD Million)
Fig. 67: Brazil market, 2018-2030 (USD Million)
Fig. 68: Mexico market, 2018-2030 (USD Million)
Fig. 69: Argentina market, 2018-2030 (USD Million)
Fig. 70: Colombia market, 2018-2030 (USD Million)
Fig. 71: MEA market, 2018-2030 (USD Million)
Fig. 72: South Africa market, 2018-2030 (USD Million)
Fig. 73: Saudi Arabia market, 2018-2030 (USD Million)
Fig. 74: UAE market, 2018-2030 (USD Million)

Companies Mentioned

  • Wuxi Biologics
  • Abzena Ltd
  • Fujifilm Diosynth Biotechnologies
  • Kbi Biopharma
  • Agc Biologics
  • Thermo Fischer Scientific Inc.
  • Curia Global, Inc
  • Genscript
  • Bionova Scientific Inc.
  • Bioxcellence (Boehringer Ingelheim Biopharmaceuticals Gmbh)
  • Stc Biologics

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedJune 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 7.3 Billion
Forecasted Market Value ( USD ) by 2030 $ 13.8 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Global Biologics Contract Development Market by Source (Mammalian, Microbial), Type (Molecular Therapy, Monoclonal Antibodies, Recombinant Proteins), Disease Indication, Phase, Service Type, End-User - Forecast 2024-2030 - Product Image

Global Biologics Contract Development Market by Source (Mammalian, Microbial), Type (Molecular Therapy, Monoclonal Antibodies, Recombinant Proteins), Disease Indication, Phase, Service Type, End-User - Forecast 2024-2030

  • Report
  • 188 Pages
  • Global
From
Biologics Market Size, Share & Trends Analysis Report By Source (Microbial, Mammalian), By Product (MABs, Recombinant Proteins, Antisense & RNAi), By Disease Category, By Manufacturing, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Biologics Market Size, Share & Trends Analysis Report By Source (Microbial, Mammalian), By Product (MABs, Recombinant Proteins, Antisense & RNAi), By Disease Category, By Manufacturing, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 120 Pages
  • Global
From
Global Biologics Contract Development & Manufacturing Organization Market by Type (Mammalian, Non-mammalian), Product Type (Biologics, Biosimilars), Disease Indication, Service Type, End-User - Forecast 2024-2030 - Product Image

Global Biologics Contract Development & Manufacturing Organization Market by Type (Mammalian, Non-mammalian), Product Type (Biologics, Biosimilars), Disease Indication, Service Type, End-User - Forecast 2024-2030

  • Report
  • 190 Pages
  • Global
From
Spine Biologics Market Size, Share & Trends Analysis Report By Product (Spinal Allografts, Bone Graft Substitutes, Cell-based Matrix), By End-use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Spine Biologics Market Size, Share & Trends Analysis Report By Product (Spinal Allografts, Bone Graft Substitutes, Cell-based Matrix), By End-use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions - Product Image

Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions

  • Report
  • 799 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.